期刊文献+

上调Decorin对口腔鳞癌荷瘤裸鼠EGFR、C-Myc、p21表达的影响

Effect of up-regulation of Decorin on expression of EGFR, C-Myc and p21 in nude mice with oral squamous cell carcinoma
下载PDF
导出
摘要 目的:探讨饰胶蛋白聚糖基因(decorin,DCN)过表达对口腔鳞癌(oral squamous cell carcinoma,OSCC)裸鼠荷瘤中表皮生长因子受体(epidermal growth factor receptor,EGFR)、骨髓细胞瘤病毒癌基因(cellular-myelocytomatosis viral oncogene,C-Myc)和细胞周期蛋白依赖性激酶抑制剂(cyclin dependent kinase inhibitor,p21)表达水平的影响。方法:通过脂质体转染法上调人口腔鳞癌细胞(HSC-3)中DCN基因的表达,使用裸鼠作为OSCC疾病模型构建载体,建立OSCC裸鼠荷瘤模型。H-E法确定各组裸鼠荷瘤组织的病理分级,免疫组织化学染色检测DCN过表达后各组裸鼠荷瘤组织中EGFR、C-Myc和p21蛋白的表达差异,RT-qPCR及Western印迹定量检测DCN过表达后各组裸鼠荷瘤组织中EGFR、C-Myc和p21在转录水平和蛋白水平上的表达差异,明确DCN过表达对OSCC裸鼠荷瘤组织中EGFR、C-Myc和p21表达的影响。采用SPSS 20.0软件包对数据进行统计学分析。结果:H-E染色结果显示,OSCC动物疾病模型构建成功。重量分析结果显示,质粒组裸鼠荷瘤组织轻于空载组和未转染组(P<0.05)。IHC结果显示,DCN、EGFR、C-Myc和p21蛋白在各组裸鼠荷瘤组织中均有表达,质粒组中DCN、EGFR和C-Myc蛋白的表达水平差异有统计学意义(P<0.05),各组中p21蛋白的表达水平无统计学差异(P>0.05)。RT-qPCR和Western印迹结果显示,DCN、EGFR、C-Myc和p21在各组裸鼠荷瘤组织中均有不同程度表达(P<0.05)。结论:上调DCN可抑制OSCC裸鼠荷瘤的生长。在OSCC裸鼠荷瘤组织中,DCN过表达下调EGFR及C-Myc的表达,上调p21的表达。DCN可能通过以上机制调节OSCC的发生、发展,发挥抑癌作用。 PURPOSE: To explore the effect of overexpression of DCN(decorin) gene on the expression of epidermal growth factor receptor(EGFR), cellular-myelocytomatosis viral oncogene(C-Myc) and cyclin dependent kinase inhibitor(p21)in tumor-bearing nude mice with oral squamous cell carcinoma(OSCC). METHODS: The expression of DCN gene in human oral squamous cell carcinoma(HSC-3) was up-regulated by liposome transfection. Nude mice were used as the carrier of OSCC. H-E staining was used to determine the pathological grade of tumor-bearing tissues in each group. Im-munohistochemistry was used to detect the expression of EGFR, C-Myc and p21 protein in tumor-bearing tissues of each group after DCN overexpression. RT-qPCR and Western blot were used to quantitatively detect the expression of EGFR,C-Myc and p21 in tumor-bearing tissues of each group after DCN overexpression, and to determine the effects of DCN overexpression on the expression of EGFR, C-Myc and p21 in tumor-bearing tissues of OSCC nude mice. SPSS 20.0 software package was used for statistical analysis. RESULTS: H-E staining showed that the animal model of OSCC was successfully constructed. The tumor-bearing tissues of nude mice in the plasmid group were significantly lighter than those in the empty vector group and non-transfected group(P<0.05). IHC results showed that DCN, EGFR, C-Myc and p21 proteins were expressed in the tumor-bearing tissues of nude mice in each group, the expression of DCN,EGFR and C-Myc proteins in the plasmid group was significantly different from the other groups(P<0.05).There was no significant differece in p21 protein expression in each group(P>0.05). RT-qPCR and Western blot results showed that DCN, EGFR, C-Myc and p21 were expressed in diffrent degrees in tumor-bearing tissues of nude mice(P<0.05). CONCLUSIONS: DCN can inhibit the growth of tumor in OSCC nude mice. In tumor-bearing tissues of nude mice with OSCC, overexpression of DCN can down-regulate the expression of EGFR and C-Myc, and up-regulate the expression of p21.DCN may play an inhibitory role in the occurrence and development of OSCC.
作者 郭梦瑶 李凯玉 聂敏海 刘旭倩 GUO Meng-yao;LI Kai-yu;NIE Min-hai;LIU Xu-qian(Department of Periodontal Mucosal Dis-eases,the Affiliated Stomatological Hospital of Southwest Medical University.Luzhou 646000;Oral&Maxillofacial Re-construction and Regeneration of Luzhou Key Laboratory,Institute of Stomatology,Southwest Medical University.Luzhou 646000,Sichuan Province,China)
出处 《上海口腔医学》 CAS 北大核心 2023年第1期40-46,共7页 Shanghai Journal of Stomatology
基金 四川省科学技术厅中央引导地方科技发展项目(2021ZYD0083) 四川省科技计划项目(2022NSFC0716) 西南医科大学应用基础重点项目(2021ZKZD010)。
关键词 饰胶蛋白聚糖 口腔鳞癌 表皮生长因子受体 骨髓细胞瘤病毒癌基因 细胞周期蛋白依赖性激酶抑制剂 Decorin Oral squamous cell carcinoma Epidermal growth factor receptor Cellular-myelocytomatosis viral oncogene Cyclin dependent kinase inhibitor
  • 相关文献

参考文献10

二级参考文献57

  • 1Santra M, Eichstetter I, Iozzo BY. An anti-oncogenic role for decorin. Down-regulation of ErbB2 leads to growth suppression and cytodifferentiation of mammary carcinoma cells { J ]. J Biol Chem. 2000 ; 275 ( 45 ) : 35153-61.
  • 2Santra M,Skorski T,Calabretta B,et al. De novo decorin gene expression suppresses the malignant phenotype in human. colon cancer cells[J]. Proc Natl Acad Sci U S A, 1995 ;92( 15 ) :7016-20
  • 3Csordas G, Santra M,Reed CC,et al. Sustained down-regulation of the epidermal growth factor receptor by decorin. A mechanism for controlling tumor growth in vivo[J]. J Biol Chem,2000 ;275(42) :32879-87.
  • 4Nash MA, Loercher AE,Freedman RS. In vitro growth inhibition of ovarian cancer cells by decorin:synergism of action between decorin and carboplatin[J]. Cancer Res, 1999 ;59:6192-96.
  • 5Koninger J, Giese NA, di Mola FF, et al. Overexpreesed decorin in pancreatic cancer:potential tumor growth inhibition and attenuation of chemotherapeutic action[J]. Clin Cancer Res,2004;10(14) :4776-83.
  • 6Tralhao JG,Schaefer L, Micegova M,et al. In vivo selective and distant killing of cancer cells using adenovirus-mediated decorin gene transfer [J]. FASEB J,2003 ;17(3) :464-6.
  • 7Matsumine A, Shintani K, Kusuzaki K, et al. Expression of decorin, a small leucine-rich proteoglycan, as a prognostic factor in soft tissue tumors[J]. J Surg Oncol,2007 ;96(5 ) :411-8.
  • 8Stander M,Naumann U,Wick W,et al. Transforming growth factor-beta and p-21 :multiple molecular targets of deeorin-mediated suppressian of neoplastic growth[J]. Cell Tissue Res,1999 ;296(2) :221-7.
  • 9Stander M, Naumann U, Dumitrescu L,et al. Decorin gene transfer-mediated suppression of TGF-beta synthesis abrogates experimental malignant glioma growth in vivo[J]. Gene Ther,1998;5(9) :1187-94.
  • 10Reed CC,Gauldie J,Iozzo RV. Suppression of tumorigenicity by adenovirus-mediated gene transfer of decorin [J]. Oncogene, 2002; 21 ( 23 ) : 3688- 95.

共引文献52

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部